NCT06253416

Brief Summary

To investigate the muscle thickness in patients with fibromyalgia (FMS) and whether there is an increase in muscle thickness, strength, and function with stretching and strengthening exercise therapy in FMS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 14, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

January 24, 2024

Last Update Submit

February 12, 2024

Conditions

Keywords

Fibromyalgiaultrasonographymuscle thicknessexercises

Outcome Measures

Primary Outcomes (1)

  • Muscle thickness

    Muscle thickness was measured with ultrasound (6-12 Megahertz: Philips purewave, multi-frequency linear probe). The anterior thigh muscle thicknesses were evaluated on quadriceps femoris. The midpoint between the upper end of the patella and the anterior iliac anterior superior iliac spine has been determined while the patients were lying on their backs and the muscle thickness is measured from this point in centimeters. Measurements were made three times in order to avoid erroneous measurements. All measurements were performed by a single physician, who had experience in musculoskeletal US.

    at the beginning of the study and again at the end of 12 weeks by the same physician.

Secondary Outcomes (5)

  • pain level

    at the beginning of the study and again at the end of 12 weeks by the same physician.

  • grip strength

    at the beginning of the study and again at the end of 12 weeks by the same physician.

  • Physical performance

    at the beginning of the study and again at the end of 12 weeks by the same physician.

  • Disease activity

    at the beginning of the study and again at the end of 12 weeks by the same physician.

  • walking speed

    at the beginning of the study and again at the end of 12 weeks by the same physician.

Study Arms (2)

Exercise group

ACTIVE COMPARATOR

The exercise group was received a home exercise program consist of stretching and strengthening exercises, which was demonstrated by a physiotherapist and supported by visual cards. The exercises were shown to the patients in practice for at least 5 repetitions three days a week for 12 weeks. The exercise tracking form was given to the patients. The patients were called by the physiotherapist every week by telephone, and were allowed to fill out the exercise tracking form and adapt to exercise. Once every four weeks, patients were called to the hospital a total of three times and exercises were shown again in practice. Exercises started with stretching exercises; for ten seconds for three times with ten seconds of rest between each exercise. After stretching exercises extremity strengthening exercises were practiced with half-kilogram weights for the upper and lower extremities, each exercise is performed ten times with ten seconds of rest.

Other: Exercise

Control group

ACTIVE COMPARATOR

The control group was told to exercise freely and without supervision. They were advised to exercise regularly, only verbally.

Other: Control

Interventions

a home exercise program consist of stretching and strengthening exercises , 5 repetitions of each exercise three days a week for 12 weeks

Exercise group
ControlOTHER

exercise freely and without supervision with their daily routine

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female patients
  • aged 18 to 65 years
  • who were diagnosed with FMS according to the 2016 American College of Rheumatology (ACR) classification criteria

You may not qualify if:

  • Patients who have a neurological or orthopedic disease that will prevent ambulation,
  • advanced heart failure, kidney failure, liver failure, pulmonary diseases that will prevent exercise,
  • inflammatory rheumatoid disease,
  • pregnancy, breastfeeding, malignancy, psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit University

Çorum, 19040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FibromyalgiaMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • MUSTAFA KESER

    HİTİT UNİVERSİTY EROL OLÇOK RESEARCH HOSPİTAL

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Participants: Patients with fibromyalgia Care provider: Physiotherapist who showed and followed the patients exercise programme Researchers were blinded to the patients groups
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective, randomized, single-blind, clinical study patients were randomized into two groups by a physiotherapist with sealed envelopes
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 24, 2024

First Posted

February 12, 2024

Study Start

June 14, 2023

Primary Completion

January 20, 2024

Study Completion

January 20, 2024

Last Updated

February 14, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Due to the confidentiality of personal data

Locations